These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 21600088

  • 1. [The evaluation of four-year highly active antiretroviral therapy in HIV-1 infected patients].
    Deng XJ, He Y, Yang L, Zou SP, Yang H, Zheng YH.
    Zhonghua Nei Ke Za Zhi; 2011 Mar; 50(3):230-4. PubMed ID: 21600088
    [Abstract] [Full Text] [Related]

  • 2. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
    Li H, Zheng YH, Shen Z, Liu M, Liu C, He Y, Chen J, Ou QY, Huang ZL.
    Zhonghua Yi Xue Za Zhi; 2007 Nov 13; 87(42):2973-6. PubMed ID: 18261327
    [Abstract] [Full Text] [Related]

  • 3. [The clinical outcome and immune reconstitution in 45 advanced AIDS patients undergoing highly active antiretroviral therapy for 12 months].
    Ruan GR, Qiu ZF, Li TS, Han Y, Xie J, Zuo LY, Ma XJ, Liu ZY, Wang AX.
    Zhonghua Nei Ke Za Zhi; 2006 Jul 13; 45(7):569-72. PubMed ID: 17074113
    [Abstract] [Full Text] [Related]

  • 4. Clinical outcomes and immune reconstitution in 103 advanced AIDS patients undergoing 12-month highly active antiretroviral therapy.
    Dai Y, Qiu ZF, Li TS, Han Y, Zuo LY, Xie J, Ma XJ, Liu ZY, Wang AX.
    Chin Med J (Engl); 2006 Oct 20; 119(20):1677-82. PubMed ID: 17097013
    [Abstract] [Full Text] [Related]

  • 5. [Cellular HIV DNA quantitative testing and its significance in Chinese AIDS patients during 48 weeks' highly-active antiretroviral treatment].
    Zheng YH, Alius DM, Chen X, He Y, He B, He M, Wang HY, Xiao SL, Luo Y, Yao YH, Lin YH, Chen Z, Zhou HY.
    Zhonghua Nei Ke Za Zhi; 2012 Sep 20; 51(9):708-12. PubMed ID: 23158922
    [Abstract] [Full Text] [Related]

  • 6. Impact of baseline CD4(+) T cell counts on the efficacy of nevirapine-based highly active antiretroviral therapy in Chinese HIV/AIDS patients: a prospective, multicentric study.
    Liu ZY, Guo FP, Han Y, Qiu ZF, Zuo LY, Li YL, Li TS.
    Chin Med J (Engl); 2009 Oct 20; 122(20):2497-502. PubMed ID: 20079166
    [Abstract] [Full Text] [Related]

  • 7. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K.
    Verh K Acad Geneeskd Belg; 2001 Oct 20; 63(5):447-73. PubMed ID: 11813503
    [Abstract] [Full Text] [Related]

  • 8. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
    Kilaru KR, Kumar A, Sippy N, Carter AO, Roach TC.
    HIV Med; 2006 Mar 20; 7(2):99-104. PubMed ID: 16420254
    [Abstract] [Full Text] [Related]

  • 9. Triple nucleoside reverse transcriptase inhibitor- vs. nonnucleoside reverse transcriptase inhibitor-containing regimens as first-line therapy: efficacy and durability in a prospective cohort of French HIV-infected patients.
    Cuzin L, Pugliese P, Bugnon F, Delpierre C, Cua E, Billaud E, Massip P, Raffi F, Dellamonica P.
    HIV Med; 2005 Nov 20; 6(6):388-95. PubMed ID: 16268820
    [Abstract] [Full Text] [Related]

  • 10. Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro.
    Jevtović DO, Salemović D, Ranin J, Pesić I, Zerjav S, Djurković-Djaković O.
    HIV Med; 2007 Mar 20; 8(2):75-9. PubMed ID: 17352762
    [Abstract] [Full Text] [Related]

  • 11. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
    McDermott AY, Terrin N, Wanke C, Skinner S, Tchetgen E, Shevitz AH.
    Clin Infect Dis; 2005 Dec 01; 41(11):1662-70. PubMed ID: 16267741
    [Abstract] [Full Text] [Related]

  • 12. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
    Moore RD, Keruly JC.
    Clin Infect Dis; 2007 Feb 01; 44(3):441-6. PubMed ID: 17205456
    [Abstract] [Full Text] [Related]

  • 13. [The therapeutic effects of highly active anti-retroviral therapy in 74 treatment-naive patients with AIDS in China].
    Chen XJ, Tang XP, Cai WP, Zhang JS, Chen JF, Liu QC, Zhong HL, He HL, Li LH, Zhao B, Shang H.
    Zhonghua Nei Ke Za Zhi; 2011 Jan 01; 50(1):59-62. PubMed ID: 21418892
    [Abstract] [Full Text] [Related]

  • 14. Patterns, predictors, and consequences of initial regimen type among HIV-infected women receiving highly active antiretroviral therapy.
    Golub ET, Benning L, Sharma A, Gandhi M, Cohen MH, Young M, Gange SJ.
    Clin Infect Dis; 2008 Jan 15; 46(2):305-12. PubMed ID: 18171267
    [Abstract] [Full Text] [Related]

  • 15. A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection.
    Hecht FM, Wang L, Collier A, Little S, Markowitz M, Margolick J, Kilby JM, Daar E, Conway B, Holte S, AIEDRP Network.
    J Infect Dis; 2006 Sep 15; 194(6):725-33. PubMed ID: 16941337
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of human immunodeficiency virus type 1-infected Chinese patients treated with highly active antiretroviral therapy for two years.
    Zhou HY, Zheng YH, Zhang CY, Chen J, He Y, Ding PP, Li H.
    Viral Immunol; 2007 Sep 15; 20(1):180-7. PubMed ID: 17425432
    [Abstract] [Full Text] [Related]

  • 17. Antiretroviral treatment outcome following genotyping in Thai children who failed dual nucleoside reverse transcriptase inhibitors.
    Bunupuradah T, Suntarattiwong P, Li A, Sirivichayakul S, Pancharoen C, Boonrak P, Puthanakit T, Kerr SJ, Ruxrungtham K, Chotpitayasunondh T, Hirschel B, Ananworanich J, HIV-NAT 013 Study Team.
    Int J Infect Dis; 2010 Apr 15; 14(4):e311-6. PubMed ID: 19699673
    [Abstract] [Full Text] [Related]

  • 18. Clinical manifestations of treatment-naive patients with acquired immunodeficiency syndrome and responses to highly active antiretroviral therapy in the Taipei Veterans General Hospital: a 5-year prospective study.
    Hsu SF, Yang SP, Chan YJ, Wang YW.
    J Microbiol Immunol Infect; 2011 Jun 15; 44(3):198-203. PubMed ID: 21524614
    [Abstract] [Full Text] [Related]

  • 19. [Safety study of 52-week highly active antiretroviral therapy in 198 HIV/AIDS Chinese patients].
    Li WJ, Dai Y, Han Y, Qiu ZF, Xie J, Zuo LY, Li YL, Li TS.
    Zhonghua Yi Xue Za Zhi; 2011 May 24; 91(19):1318-22. PubMed ID: 21756757
    [Abstract] [Full Text] [Related]

  • 20. Response to antiretroviral therapy among patients exposed to three classes of antiretrovirals: results from the EuroSIDA study.
    Mocroft A, Phillips AN, Friis-Møller N, Colebunders R, Johnson AM, Hirschel B, Saint-Marc T, Staub T, Clotet B, Lundgren JD, EuroSIDA study group.
    Antivir Ther; 2002 Mar 24; 7(1):21-30. PubMed ID: 12008784
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.